by Spoke Blog Admin | Jun 25, 2026 | Clinical Trials, Crohns Disease, Ulcerative Colitis
Inflammatory Bowel Disease (IBD), which primarily includes Crohn’s disease and Ulcerative Colitis, affects millions of people worldwide and continues to pose significant challenges for both patients and healthcare providers. These chronic inflammatory conditions of...
by Spoke Blog Admin | May 30, 2026 | Crohns Disease, Ulcerative Colitis
Inflammatory bowel disease (IBD) affects millions of people worldwide, yet many patients are still confused about the difference between Crohn’s disease and ulcerative colitis. While both conditions fall under the umbrella of IBD and share similar symptoms, they are...
by Spoke Blog Admin | Apr 20, 2026 | Crohns Disease
Crohn’s disease is often thought of as a digestive condition—and while it primarily affects the gastrointestinal tract, its impact goes far beyond the gut. As a form of inflammatory bowel disease (IBD), Crohn’s is a systemic condition driven by an overactive immune...
by Spoke Blog Admin | Mar 20, 2026 | Clinical Trials, Crohns Disease, Ulcerative Colitis
Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, is a lifelong condition that can be unpredictable, frustrating, and, at times, difficult to manage. While many patients find relief through standard treatments, others continue to...
by Spoke Blog Admin | Feb 20, 2026 | Clinical Trials, Crohns Disease
Crohn’s disease is a chronic inflammatory condition of the digestive tract that affects millions of people worldwide. Its symptoms — abdominal pain, diarrhoea, fatigue, weight loss, and bowel damage — can be debilitating and unpredictable. Despite significant...
by Spoke Blog Admin | Jan 20, 2026 | Clinical Trials, Crohns Disease
A new year often brings renewed motivation — a desire to take control of health, establish better habits, and move forward with clarity. For individuals living with inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, this “fresh start”...
